F. Di Fiore

1.1k total citations
31 papers, 629 citations indexed

About

F. Di Fiore is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, F. Di Fiore has authored 31 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in F. Di Fiore's work include Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (5 papers) and Esophageal and GI Pathology (5 papers). F. Di Fiore is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (5 papers) and Esophageal and GI Pathology (5 papers). F. Di Fiore collaborates with scholars based in France, Italy and Belgium. F. Di Fiore's co-authors include Pierre Michel, B Paillot, David Tougeron, H. Hamidou, Isabelle Iwanicki–Caron, S. Thureau, Olivier Rigal, M F Hellot, M Antonietti and Philippe Ducrotté and has published in prestigious journals such as Journal of Clinical Oncology, FEBS Letters and British Journal of Cancer.

In The Last Decade

F. Di Fiore

29 papers receiving 617 citations

Peers

F. Di Fiore
Steven Ades United States
Gerard Abood United States
Giovanni de Pretis Italy
Peadar S. Waters Australia
Zaher Lakkis France
Steven C. Agle United States
Chao‐Sheng Liao Taiwan
Weidong Kong Canada
Kenneth Seier United States
Jean‐Philippe Adam France
Steven Ades United States
F. Di Fiore
Citations per year, relative to F. Di Fiore F. Di Fiore (= 1×) peers Steven Ades

Countries citing papers authored by F. Di Fiore

Since Specialization
Citations

This map shows the geographic impact of F. Di Fiore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Di Fiore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Di Fiore more than expected).

Fields of papers citing papers by F. Di Fiore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Di Fiore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Di Fiore. The network helps show where F. Di Fiore may publish in the future.

Co-authorship network of co-authors of F. Di Fiore

This figure shows the co-authorship network connecting the top 25 collaborators of F. Di Fiore. A scholar is included among the top collaborators of F. Di Fiore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Di Fiore. F. Di Fiore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aparicio, Thomas, Julie Henriques, Magali Svrcek, et al.. (2023). 650P Genomic profiling of small bowel adenocarcinoma: A pooled analysis. Annals of Oncology. 34. S456–S456. 2 indexed citations
2.
3.
Perdrix, Anne, Justine Lequesne, Maxime Fontanilles, et al.. (2020). 265P Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients. Annals of Oncology. 31. S344–S345. 1 indexed citations
4.
Tuech, Jean‐Jacques, Alice Gangloff, F. Di Fiore, et al.. (2020). Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic. Journal of Visceral Surgery. 157(3). S7–S12. 77 indexed citations
5.
Beaussire, Ludivine, Anne Perdrix, David Sefrioui, et al.. (2017). Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. Annals of Oncology. 28. v58–v58. 3 indexed citations
6.
7.
Pfister, Christian, et al.. (2015). Étude des facteurs pronostiques pour le carcinome rénal métastatique traité par une deuxième ligne de thérapies ciblées. Progrès en Urologie. 26(1). 16–23. 1 indexed citations
8.
Nouhaud, François‐Xavier, et al.. (2014). Valeur pronostique de la toxicité induite par les thérapies ciblées dans le carcinome rénal métastatique. Progrès en Urologie. 24(9). 563–571. 3 indexed citations
9.
Aparicio, Thomas, M. Svrcek, Aziz Zaanan, et al.. (2013). Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. British Journal of Cancer. 109(12). 3057–3066. 77 indexed citations
10.
Fiore, F. Di, et al.. (2011). Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib. British Journal of Cancer. 105(12). 1811–1813. 42 indexed citations
11.
Tougeron, David, Michel Scotté, H. Hamidou, et al.. (2011). Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?. Journal of Surgical Oncology. 105(8). 761–766. 11 indexed citations
12.
Lecleire, Stéphane, M Antonietti, Isabelle Iwanicki–Caron, et al.. (2011). Lugol chromo-endoscopy versus Narrow Band Imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study. Diseases of the Esophagus. 24(6). 418–422. 20 indexed citations
13.
Tougeron, David, H. Hamidou, F. Dujardin, et al.. (2009). Unusual skeletal muscle metastasis from gastric adenocarcinoma. Gastroentérologie Clinique et Biologique. 33(6-7). 485–487. 12 indexed citations
14.
Fiore, F. Di, Frédéric Bibeau, A. Lamy, et al.. (2009). TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy. British Journal of Cancer. 100(8). 1330–1335. 72 indexed citations
15.
Tougeron, David, F. Di Fiore, S. Thureau, et al.. (2008). Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. British Journal of Cancer. 99(10). 1586–1592. 95 indexed citations
16.
Lecleire, Stéphane, M Antonietti, F. Di Fiore, et al.. (2007). Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity. Alimentary Pharmacology & Therapeutics. 25(8). 955–963. 16 indexed citations
17.
Lecleire, Stéphane, F. Di Fiore, Emmanuel Ben-Soussan, et al.. (2006). Prior chemoradiotherapy is associated with a higher life‐threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Alimentary Pharmacology & Therapeutics. 23(12). 1693–1702. 58 indexed citations
18.
Michel, Pierre, Antoine Adenis, F. Di Fiore, et al.. (2006). Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. British Journal of Cancer. 95(6). 705–709. 38 indexed citations
19.
Daniele, Bruno, Federica Perrone, Secondo Lastoria, et al.. (2000). Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis.. PubMed. 20(2B). 1249–51. 10 indexed citations
20.
Ammendola, Rosario, F. Di Fiore, Franca Esposito, et al.. (1995). Differentially expressed mRNAs as a consequence of oxidative stress in intact cells. FEBS Letters. 371(3). 209–213. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Ades Breakdown of academic impact, for papers by Gerard Abood Breakdown of academic impact, for papers by Giovanni de Pretis Breakdown of academic impact, for papers by Peadar S. Waters Breakdown of academic impact, for papers by Zaher Lakkis Breakdown of academic impact, for papers by Steven C. Agle Breakdown of academic impact, for papers by Chao‐Sheng Liao Breakdown of academic impact, for papers by Weidong Kong Breakdown of academic impact, for papers by Kenneth Seier Breakdown of academic impact, for papers by Jean‐Philippe Adam
Rankless by CCL
2026